Representative Matters
代表事项
REFERENZMANDATE
Experience
She has recently represented:
- Teva Pharmaceuticals in patent litigation concerning its branded treatment for Parkinson’s disease, Azilect®. Teva prevailed after a bench trial in May 2013 before Judge Claire C. Cecchi in the U.S. District Court, District of New Jersey. Judge Cecchi ruled that Teva’s patent covering the use of Azilect® to treat Parkinson’s disease was valid and infringed. (Trial and appellate counsel)
- Teva Pharmaceuticals in patent litigation challenging a patent claiming Lovenox®, a treatment for deep vein thrombosis. Judge Mariana Pfaelzer ruled in Teva’s favor after a bench trial, finding that the patent was unenforceable as a result of inequitable conduct. This ruling was affirmed by the Federal Circuit in 2008. (Trial and appellate counsel)
- Teva Pharmaceuticals in patent litigation challenging patents covering the pharmaceutical products Aricept®, Cubicin®, Avandia® and Levaquin®. (Trial counsel)